SHL Telemedicine Ltd
LSE:0QMX

Watchlist Manager
SHL Telemedicine Ltd Logo
SHL Telemedicine Ltd
LSE:0QMX
Watchlist
Price: 19 CHF 24.35% Market Closed
Market Cap: CHf274.9m

Intrinsic Value

0QMX price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The intrinsic value for SHL Telemedicine Ltd (0QMX) under the Base Case is 20.45 CHF. Compared with the current market price of 19 CHF, the stock appears Undervalued by 7% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

0QMX Intrinsic Value
20.45 CHF
Undervaluation 7%
Intrinsic Value
Price CHf19
Bear Case
Base Case
Bull Case
Monitor 0QMX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CHf16.36
Get notified when the price drops into your buy zone
Intrinsic Value CHf20.45
Current Price CHf19
Margin of Safety 20% CHf16.36
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 0QMX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0QMX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for SHL Telemedicine Ltd.

Explain Valuation
Alternatives to 0QMX

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SHLTN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 0QMX stock?

The intrinsic value for SHL Telemedicine Ltd (0QMX) under the Base Case is 20.45 CHF.

Is 0QMX stock undervalued or overvalued?

Compared with the current market price of 19 CHF, the stock appears Undervalued by 7% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett